cardiac arrest.
Pink was first developed in the 1970’s by pharmaceutical company UpJohn as a replacement to morphine. Today, abuse of the drug rivals heroin, prescription painkillers and other novel opioids. Law enforcement officials have found it in both powder and tablet form.
Users have been known to take it as a single substance, as well as in combination with fentanyl and heroin. Confiscated bags have even been marked with logos, resembling a heroin sale.
Since Pink is produced by chemists in offshore labs, the drug’s purity, identity and quantity are unknown. According to the press release, anyone participating in recreational use will have a “Russian Roulette” scenario on their hands.
The DEA’s final order is available for viewing in the Federal Register, further detailing the administration’s findings regarding Pink. It will remain a Schedule I substance for the next 24 months. A 12-month extension could be filed if the DEA needs more evidence to determine whether or not Pink should be permanently scheduled.
“Something you think will turn out to be a night of fun may turn out to be your last night,” Patterson said.
